Anthony Campanella
Physician Assistant · Atlanta, GANPI 1043808801
Payments from drug & device makers
Across 592 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Johnson & Johnson$1K
- AbbVie$901
- Alkermes, Inc.$866
- plus $6K from 23 others
What the payments were for
- Food & beverage$12,64498%
- Education$2102%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 77 | $1,478 |
| Otsuka America Pharmaceutical, Inc. | 61 | $1,307 |
| Neurocrine Biosciences, Inc. | 38 | $1,213 |
| Johnson & Johnson | 44 | $1,163 |
| AbbVie | 57 | $901 |
| Alkermes, Inc. | 29 | $866 |
| Tris Pharma Inc | 37 | $843 |
| Teva Pharmaceuticals USA, Inc. | 44 | $778 |
| Supernus Pharmaceuticals, Inc. | 20 | $542 |
| Vanda Pharmaceuticals Inc. | 14 | $479 |
| Axsome Therapeutics, Inc. | 17 | $436 |
| Corium, LLC | 21 | $372 |
| Lundbeck LLC | 22 | $370 |
| Neos Therapeutics, LP | 24 | $302 |
| E.r. Squibb & Sons, L.L.C. | 11 | $299 |
| Ironshore Pharmaceuticals Inc. | 19 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $220 |
| Luye Pharma (USA) Ltd. | 3 | $177 |
| Bausch Health US, LLC | 8 | $165 |
| Indivior Inc. | 4 | $135 |
| Noven Pharmaceuticals, Inc. | 1 | $95 |
| Collegium Pharmaceutical, Inc. | 4 | $90 |
| Sunovion Pharmaceuticals Inc. | 8 | $85 |
| Acadia Pharmaceuticals Inc | 3 | $66 |
| Noven Therapeutics, LLC | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Aytu Biopharma, Inc. | 4 | $41 |
| Tempus AI, Inc | 1 | $16 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$934
- INGREZZA$259
- Quillichew ER$250
- Dyanavel XR$250
- Quillivant$250
- CAPLYTA$244
- QELBREE$239
- REXULTI$237
- Azstarys$125
- VRAYLAR$125
- ERZOFRI EXTENDED-RELEASE$125
- Fanapt$122
- SPRAVATO$114
- UZEDY$101
How this compares
$12,854 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 63 | $185,415 |
| AustedoDeutetrabenazine | 23 | $162,452 |
| Austedo XrDeutetrabenazine | 14 | $124,365 |
| VraylarCariprazine Hcl | 28 | $45,342 |
| NuedextaDextromethorphan Hbr/Quinidine | 12 | $18,530 |
| Divalproex Sodium ErDivalproex Sodium | 60 | $3,791 |
| Paliperidone ErPaliperidone | 29 | $3,046 |
| Aripiprazole | 45 | $2,645 |
| Olanzapine | 65 | $2,374 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $2,013 |
| Quetiapine Fumarate | 118 | $1,707 |
| Ziprasidone Hcl | 15 | $1,298 |
| Divalproex Sodium | 28 | $1,145 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $1,011 |
| Bupropion XlBupropion Hcl | 43 | $957 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr | $778 | $286,81737 claims |
| Johnson & JohnsonInvega Sustenna | $1,163 | $185,41563 claims |
| AbbVieVraylar | $901 | $45,34228 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Jaime AckermanAtlanta$84K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Jennifer YoungAtlanta$32K
- Kia CampbellAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.